ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Zinder Report Asks VCP To Switch Most Research To Grants, Spread Work Among More Scientists, Change Review Groups

March 22, 1974

Agency Asks GnRH Sponsors To Add Warnings On Labels

October 22, 2010

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976

L-PAM, Less Than Radical Surgery Results Holding Up, New Breast Cancer Studies Sought

September 12, 1975

Funding Opportunities

January 24, 2003

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980